Feied C F
Department of Emergency Medicine, George Washington University Medical Center, Washington, DC 20037.
Semin Dermatol. 1993 Jun;12(2):135-49.
There have been many case reports of deep vein thrombosis and pulmonary thromboembolism in patients undergoing sclerotherapy for the treatment of varicose veins, but the true incidence of venous thromboembolism in this patient population is unknown. Patients who develop deep vein thrombosis while being treated for varicose veins do so either because of an error in treatment or because the patient suffers from some underlying hypercoagulable state. It is possible to identify prospectively many patients who are at especially high risk for venous thromboembolism by virtue of genetic predisposition, past or recent medical problems, or environmental factors. When sclerotherapy is used in such patients, special efforts must be made to protect against the development of venous thrombosis during treatment.
已有许多关于接受硬化疗法治疗静脉曲张的患者发生深静脉血栓形成和肺血栓栓塞的病例报告，但该患者群体中静脉血栓栓塞的真实发生率尚不清楚。在接受静脉曲张治疗时发生深静脉血栓形成的患者，其发生原因要么是治疗失误，要么是患者存在某种潜在的高凝状态。凭借遗传易感性、既往或近期的医疗问题或环境因素，有可能前瞻性地识别出许多静脉血栓栓塞风险特别高的患者。当对这类患者使用硬化疗法时，治疗期间必须特别努力预防静脉血栓形成。
